Skip to content
Open access

Knowledge-Driven Feature Selection with the Grouping–Scoring–Modeling Framework for Biomarker Discovery in High-Dimensional Transcriptomic Data

Sep 2026 · Applied Sciences · 0 citations · 49 references

TL;DR

The Grouping–Scoring–Modeling (G-S-M) framework is proposed, a knowledge-driven pipeline that anchors feature selection in established disease–gene associations that provides a reproducible computational framework for candidate biomarker discovery.

Abstract

Biomarker discovery from high-dimensional transcriptomic data is frequently hindered by the “curse of dimensionality” and model selection bias. To address this, we propose the Grouping–Scoring–Modeling (G-S-M) framework, a knowledge-driven pipeline that anchors feature selection in established disease–gene associations. G-S-M operates within a 100-iteration Monte Carlo ensemble architecture utilizing internal cross-validation to ensure unbiased evaluation. We evaluated this framework on seven cancer datasets, where it demonstrated robust discrimination with an overall mean F1-score of 0.84 across all datasets. The framework achieved the strongest performance on Acute Myeloid Leukemia (mean F1 = 0.99, AUC-ROC = 1.00) and maintained competitive accuracy even on challenging cohorts, while producing biologically interpretable gene panels traceable to named disease associations. Permutation tests (10,000 iterations) confirmed statistically significant disease–gene enrichment (p < 0.0001) in five of seven datasets, and independent protein interaction network analyses demonstrated significant enrichment of the selected features. Released as an open-source software suite with interactive interfaces, G-S-M provides a reproducible computational framework for candidate biomarker discovery.

Read PDF

Similar papers

Conference Sep 2026

XAI-Enabled Ensemble Learning for Reliable Multi Omics Biomarker Discovery in Cancer

Early discovery of cancer biomarkers in a consistent manner still represents an important challenge, because these are obtained from multi-omics data whose high dimensionality, heterogeneity and noise. Although deep learning outperforms conventional models for cancer analysis prediction, single-model methods usually la...

Kok Swee Sim, Md. Tahidul Islam, Md. Mijanur Rahman et al. · 0 citations
Open access Sep 2026

A Systematic Machine Learning Framework for Evaluating and Ranking Omics Layers in Cancer Drug Response Prediction

Cluster analysis showed the importance of well-defined clusters, indicating that while silhouette scores were linked to prediction success, biological variability also played a critical role, indicating that while silhouette scores were linked to prediction success, biological variability also played a critical role.

Sara Amjad, M. M. Sufyan Beg, Mohd. Azhar Aziz · 0 citations
Open access Sep 2026

Dimensionality reduction and metabolite panel derivation in urinary metabolomics based on Random Forest with Gini index feature selection.

These findings highlight the advantage of a unified, supervised tree-based strategy capable of delivering stable classification and interpretable dimensionality reduction across independent untargeted metabolomics platforms, providing a structured and transferable framework for metabolomics-driven biomarker discovery a...

Markus Zetes, Vlad Moisoiu, Carmen Socaciu et al. · 0 citations
Open access Aug 2026

Interpretable biomarker discovery from small-sample microarray datasets using XGBoost rank aggregation and SVM-RFECV

Motivation High-dimensional microarray datasets remain valuable for cancer biomarker discovery, but their small sample sizes make robust and interpretable feature selection challenging. Efficient workflows are needed to derive compact gene signatures while preserving biological interpretability. Results We developed a...

Mashiyat Mahjabin Prapty, Mohammad Saifur Rahman · 0 citations
Preprint Oct 2026

Community-Centers Identify Robust Biomarker in High-Dimensional, Low-Sample-Size Gene Expression Data

High-dimensional, low-sample-size bulk gene expression data poses a fundamental challenge in transcriptomics, which typically includes tens of thousands of genes but relatively few samples, leading to overfitting and unstable selection for key features as biomarkers. We propose a regression by community centers (RCC) f...

Rui-Qi Li, Te Bai, R. Lambiotte et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.